TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 2 | 1 | 2 | 1 | 2 | 7 | 23 | 43 | 47 | 20 |
| P | %wins | 100 | 100 | 50 | 100 | 50 | 100 | 83 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/13/14 17:20 | 3/11/14 | ALKS | Alkermes Plc. | Health | Drug | Pharmaceutical Preparations | Dixon Wendy L | D | P | 76 | 47.37 | 33 | 2 | New | 2 | D | 171 | 104 | 34 | 17 | -2 | -12 | -1 | 1 | 0 | 3 | -5 | 5 | -2 | 45 | |||
11/21/11 16:05 | 11/17/11 | INCY | Incyte Corp | DE | Health | Biolab | Commercial Physical & Biologi | Dixon Wendy L | DE | D | P | 100 | 13.40 | 31 | 8 | New | 8 | D | 58 | -21 | -33 | -12 | -25 | -11 | -5 | -3 | 2 | 1 | 19 | 40 | 88 | 48 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |